These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

416 related articles for article (PubMed ID: 29183741)

  • 1. Arginine as an Excipient for Protein Freeze-Drying: A Mini Review.
    Stärtzel P
    J Pharm Sci; 2018 Apr; 107(4):960-967. PubMed ID: 29183741
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Freeze-Drying of L-Arginine/Sucrose-Based Protein Formulations, Part 2: Optimization of Formulation Design and Freeze-Drying Process Conditions for an L-Arginine Chloride-Based Protein Formulation System.
    Stärtzel P; Gieseler H; Gieseler M; Abdul-Fattah AM; Adler M; Mahler HC; Goldbach P
    J Pharm Sci; 2015 Dec; 104(12):4241-4256. PubMed ID: 26422647
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Freeze drying of L-arginine/sucrose-based protein formulations, part I: influence of formulation and arginine counter ion on the critical formulation temperature, product performance and protein stability.
    Stärtzel P; Gieseler H; Gieseler M; Abdul-Fattah AM; Adler M; Mahler HC; Goldbach P
    J Pharm Sci; 2015 Jul; 104(7):2345-58. PubMed ID: 25994980
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Applications of Freezing and Freeze-Drying in Pharmaceutical Formulations.
    Izutsu KI
    Adv Exp Med Biol; 2018; 1081():371-383. PubMed ID: 30288720
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Application of Amino Acids in Freeze Dried Protein Formulations.
    Stärtzel P
    PDA J Pharm Sci Technol; 2016 Sep; ():. PubMed ID: 27593690
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of Arginine on the Aggregation of Protein in Freeze-Dried Formulations Containing Sugars and Polyol: 1-Formulation Development.
    Hackl E; Darkwah J; Smith G; Ermolina I
    AAPS PharmSciTech; 2018 Feb; 19(2):896-911. PubMed ID: 29047017
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fundamentals of freeze-drying.
    Nail SL; Jiang S; Chongprasert S; Knopp SA
    Pharm Biotechnol; 2002; 14():281-360. PubMed ID: 12189727
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of Protein-Excipient Microheterogeneity in Biopharmaceutical Solid-State Formulations by Confocal Fluorescence Microscopy.
    Koshari SH; Ross JL; Nayak PK; Zarraga IE; Rajagopal K; Wagner NJ; Lenhoff AM
    Mol Pharm; 2017 Feb; 14(2):546-553. PubMed ID: 28094996
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mannitol/l-Arginine-Based Formulation Systems for Freeze Drying of Protein Pharmaceuticals: Effect of the l-Arginine Counter Ion and Formulation Composition on the Formulation Properties and the Physical State of Mannitol.
    Stärtzel P; Gieseler H; Gieseler M; Abdul-Fattah AM; Adler M; Mahler HC; Goldbach P
    J Pharm Sci; 2016 Oct; 105(10):3123-3135. PubMed ID: 27506270
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Significant Drying Time Reduction Using Microwave-Assisted Freeze-Drying for a Monoclonal Antibody.
    Gitter JH; Geidobler R; Presser I; Winter G
    J Pharm Sci; 2018 Oct; 107(10):2538-2543. PubMed ID: 29890173
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effects of formulation variables on the stability of freeze-dried human growth hormone.
    Pikal MJ; Dellerman KM; Roy ML; Riggin RM
    Pharm Res; 1991 Apr; 8(4):427-36. PubMed ID: 1871037
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Physical characterisation of formulations for the development of two stable freeze-dried proteins during both dried and liquid storage.
    Passot S; Fonseca F; Alarcon-Lorca M; Rolland D; Marin M
    Eur J Pharm Biopharm; 2005 Aug; 60(3):335-48. PubMed ID: 15894475
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stability of buffer-free freeze-dried formulations: A feasibility study of a monoclonal antibody at high protein concentrations.
    Garidel P; Pevestorf B; Bahrenburg S
    Eur J Pharm Biopharm; 2015 Nov; 97(Pt A):125-39. PubMed ID: 26455339
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The impact of drying method and formulation on the physical properties and stability of methionyl human growth hormone in the amorphous solid state.
    Abdul-Fattah AM; Lechuga-Ballesteros D; Kalonia DS; Pikal MJ
    J Pharm Sci; 2008 Jan; 97(1):163-84. PubMed ID: 17722086
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ectoine and Hydroxyectoine Stabilize Antibodies in Spray-Dried Formulations at Elevated Temperature and during a Freeze/Thaw Process.
    Nayak PK; Goode M; Chang DP; Rajagopal K
    Mol Pharm; 2020 Sep; 17(9):3291-3297. PubMed ID: 32672979
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of dextran on thermal properties, product quality attributes, and monoclonal antibody stability in freeze-dried formulations.
    Haeuser C; Goldbach P; Huwyler J; Friess W; Allmendinger A
    Eur J Pharm Biopharm; 2020 Feb; 147():45-56. PubMed ID: 31866444
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Component crystallization and physical collapse during freeze-drying of L-arginine-citric acid mixtures.
    Yamaki T; Ohdate R; Nakadai E; Yoshihashi Y; Yonemochi E; Terada K; Moriyama H; Izutsu K; Yomota C; Okuda H; Kawanishi T
    Chem Pharm Bull (Tokyo); 2012; 60(9):1176-81. PubMed ID: 22976327
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Distinct effects of sucrose and trehalose on protein stability during supercritical fluid drying and freeze-drying.
    Jovanović N; Bouchard A; Hofland GW; Witkamp GJ; Crommelin DJ; Jiskoot W
    Eur J Pharm Sci; 2006 Mar; 27(4):336-45. PubMed ID: 16338123
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of Arginine on the Aggregation of Protein in Freeze-Dried Formulations Containing Sugars and Polyol: II. BSA Reconstitution and Aggregation.
    Hackl E; Darkwah J; Smith G; Ermolina I
    AAPS PharmSciTech; 2018 Oct; 19(7):2934-2947. PubMed ID: 29980982
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Freeze drying formulation using microscale and design of experiment approaches: a case study using granulocyte colony-stimulating factor.
    Grant Y; Matejtschuk P; Bird C; Wadhwa M; Dalby PA
    Biotechnol Lett; 2012 Apr; 34(4):641-8. PubMed ID: 22187075
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.